Nicotinic pharmacophore: The pyridine N of nicotine and carbonyl of acetylcholine hydrogen bond across a subunit interface to a backbone NH
- 28 June 2010
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 107 (30) , 13206-13211
Abstract
Pharmacophore models for nicotinic agonists have been proposed for four decades. Central to these models is the presence of a cationic nitrogen and a hydrogen bond acceptor. It is now well-established that the cationic center makes an important cation-π interaction to a conserved tryptophan, but the donor to the proposed hydrogen bond acceptor has been more challenging to identify. A structure of nicotine bound to the acetylcholine binding protein predicted that the binding partner of the pharmacophore’s second component was a water molecule, which also hydrogen bonds to the backbone of the complementary subunit of the receptors. Here we use unnatural amino acid mutagenesis coupled with agonist analogs to examine whether such a hydrogen bond is functionally significant in the α4β2 neuronal nAChR, the receptor most associated with nicotine addiction. We find evidence for the hydrogen bond with the agonists nicotine, acetylcholine, carbamylcholine, and epibatidine. These data represent a completed nicotinic pharmacophore and offer insight into the design of new therapeutic agents that selectively target these receptors.Keywords
This publication has 39 references indexed in Scilit:
- Insight in nAChR subtype selectivity from AChBP crystal structuresBiochemical Pharmacology, 2009
- Probing the role of the cation–π interaction in the binding sites of GPCRs using unnatural amino acidsProceedings of the National Academy of Sciences, 2009
- Nicotine binding to brain receptors requires a strong cation–π interactionNature, 2009
- An Intersubunit Hydrogen Bond in the Nicotinic Acetylcholine Receptor That Contributes to Channel GatingJournal of Biological Chemistry, 2008
- A conserved salt bridge critical for GABAAreceptor function and loop C dynamicsProceedings of the National Academy of Sciences, 2008
- Improved amber and opal suppressor tRNAs for incorporation of unnatural amino acids in vivo. Part 2: Evaluating suppression efficiencyRNA, 2007
- Improved amber and opal suppressor tRNAs for incorporation of unnatural amino acids in vivo. Part 1: Minimizing misacylationRNA, 2007
- Structure-guided drug design: Conferring selectivity among neuronal nicotinic receptor and acetylcholine-binding protein subtypesBiochemical Pharmacology, 2007
- A Chemo-Enzymatic Route to Enantiomerically Pure Cyclic Tertiary AminesJournal of the American Chemical Society, 2006
- Using Physical Chemistry To Differentiate Nicotinic from Cholinergic Agonists at the Nicotinic Acetylcholine ReceptorJournal of the American Chemical Society, 2004